Financial cycles of acquisition and 'buybacks' threaten public access to breakthrough drugs
New research on the financial practices surrounding a 'wonder drug' with a more than 90% cure rate for hepatitis C - a blood-borne infection that damages the liver over many years - shows how this medical breakthrough, developed ...
Jul 28, 2016
0
2